Meglitinide analogues for type 2 diabetes mellitus (Review)
BACKGROUND: In type 2 diabetes mellitus, impairment of insulin secretion is an important component of the disease. Meglitinide analogues are a class of oral hypoglycaemic agents that increase insulin secretion, in particular, during the early phase of insulin release. OBJECTIVES: The aim of this re...
Main Authors: | Black, Corri (Author), Donnelly, Peter (Author), McIntyre, Linda (Author), Royle, Pamela (Author), Shepherd, Jonathan J. (Author), Thomas, Sian (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
2009-01-21.
|
Subjects: | |
Online Access: | Get fulltext |
Similar Items
-
Etude des esters de métabolites carboxyliques et des analogues du méglitinide :effets insulinotropes et extrainsulaires
by: Bakkali Nadi, Abdellatif
Published: (1998) -
Glucagon-like peptide analogues for type 2 diabetes mellitus: systematic review and meta-analysis
by: Sharma Pawana, et al.
Published: (2010-12-01) -
Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter
by: Naina Mohamed Pakkir Maideen, et al.
Published: (2018-08-01) -
Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
by: McIntyre HD
Published: (2010-11-01) -
Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus
by: Peter J Donovan, et al.
Published: (2010-11-01)